← Leaderboards
David P Paar
University Of Texas Medical Br Galveston
$50,352
Attributed
$50,352
Total exposure
6
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$50,352 · 6
By mechanism
M01$50,352 · 6
Top collaborators
No co-investigators on record.
Most similar at University Of Texas Medical Br Galveston
Same institution · by research overlap
- Daryl T Lau$5,136,284
- Stephen K Tyring$3,207,560
- Abbey B Berenson$17,801,407
- Richard B Pollard$5,266,302
- Randall J Urban$29,729,784
Others in their field
Top investigators on “Clinical Research”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,040,569,537
- Leonard Freedman · Leidos Biomedical Research, Inc.$975,089,882
- Lawrence Corey · Fred Hutchinson Cancer Center$739,766,552
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Jeffrey P Krischer · University Of South Florida$611,867,176
- Barton F Haynes · Duke University$538,862,577
Research focus
Clinical ResearchHuman SubjectAntiviral AgentsInfluenzaDrug Screening /EvaluationMicroorganism Disease ChemotherapyEnzyme InhibitorsHuman Therapy EvaluationPharmacokineticsDrug Adverse EffectPatient Oriented ResearchReverse Transcriptase InhibitorsAntiaids AgentPlacebosProtease InhibitorRitonavirAids TherapyYoung Adult Human (21-34)ChemopreventionClinical Trial Phase IClinical Trial Phase IiCombination TherapyDrug InteractionsExo Alpha Sialidase
Grant awards (10)
ACTG 5135: A PHASE II, RANDOMIZED, OPEN-LABEL STUDY COMPARING FIXED-DOSE VERSUS$10,761
M01 · FY2004 · RR
ACTG A5093: Pharmacokinetic interactions between Depo-$4,708
M01 · FY2004 · RR
A DOUBLE-BLIND, RANDOMIZED, PLACEBO CONTROLLED STUDY OF TWO DOSES OF$672
M01 · FY2004 · RR
Sudy of Ro64-0796 for treatment against human influenza virus$0
M01 · FY2002 · RR
Study of Ro64-0796 for treatment against human influenza virus in chronically ill$0
M01 · FY2002 · RR
Sudy of Ro64-0796 for treatment against human influenza virus$0
M01 · FY2001 · RR
Study of Ro64-0796 for treatment against human influenza virus in chronically ill$0
M01 · FY2001 · RR
CONTROLLED STUDY OF GS 4104 FOR PROPHYLAXIS AGAINST HUMAN INFLUENZA VIRUS$34,211
M01 · FY2000 · RR
Sudy of Ro64-0796 for treatment against human influenza virus$0
M01 · FY2000 · RR
Study of Ro64-0796 for treatment against human influenza virus in chronically ill$0
M01 · FY2000 · RR